GLAXOSMITHKLINE PLC

GSK
Delayed Quote. Delayed  - 04/15 11:35:28 am
1348.4GBX +4.56%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Other Pharmaceuticals
GlaxoSmithkline plc is the world's No. 2 pharmaceutical group. Net sales break down by family of products as follows:
- pharmaceutical products (50%): intended for respiratory diseases (64.9% of net sales), HIV infection (28.6%), immune system disorders (4.3%) ) and cancer (2.2%);
- OTC and parapharmaceutical medicine (29.4%);
- vaccines (20.5%);
- other (0.1%).
Net sales are distributed geographically as follows: the United Kingdom (2.9%), the United States (42.7%) and other (54.4%).

Number of employees : 94 066 people.
Sales per Business
20192020
GBP
(in Million)
%GBP
(in Million)
%
Pharmaceuticals 17,55452% 17,05650%
Consumer Healthcare 8,99526.6% 10,03329.4%
Vaccines 7,15721.2% 6,98220.5%
Corporate and Other Unallocated 48.000.1% 28.000.1%
Sales per region
20192020
GBP
(in Million)
%GBP
(in Million)
%
United States 13,89041.2% 14,55642.7%
Rest of World 11,79534.9% 11,37933.4%
Europe 7,12721.1% 7,18421.1%
United Kingdom 942.002.8% 980.002.9%
Managers
Name Title
Emma N. Walmsley Chief Executive Officer & Executive Director
Iain James Mackay Chief Financial Officer & Executive Director
Jonathan Richard Symonds Non-Executive Chairman
Karenann K. Terrell Chief Digital & Technology Officer
Hal V. Barron Executive Director & Chief Scientific Officer
Jon Ellis VP & Head-Technology Business Development
Amy Altshul SVP-Legal, Research & Development
Nick Hirons Senior Vice President-Global Ethics & Compliance
Judy Carol Lewent Independent Non-Executive Director
Lynn Laverty Elsenhans Independent Non-Executive Director
Shareholders
Name Equities %
The Vanguard Group, Inc. 138,925,000 2.76%
BlackRock Fund Advisors 131,211,690 2.61%
BlackRock Investment Management (UK) Ltd. 128,982,522 2.56%
Norges Bank Investment Management 125,399,000 2.49%
Capital Research & Management Co. (Global Investors) 108,509,979 2.16%
Dodge & Cox 99,377,874 1.98%
State Street Global Advisors Ltd. 66,661,377 1.33%
BlackRock Advisors (UK) Ltd. 65,153,969 1.30%
Schroder Investment Management Ltd. 63,637,317 1.26%
Capital Research & Management Co. (World Investors) 61,076,263 1.21%
Company contact information
980 Great West Road
TW8 9GS Brentford, Greater London


Phone : +44 (0)20 8047 5000
Fax : +44 (0)20 8047 7807
web site : http://www.gsk.com
Markets and indexes
-
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, FTSE Eurotop 100, Low Carbon 100 Europe, Stoxx Europe 50, STOXX Europe 600, Stoxx Global 200, Stoxx UK 50
Stock Exchange Codes
- Bloomberg Code :  GSK:LN
- Reuters Code :  GSK.L
- Datastream Code :  GSK
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
GLAXOSMITHKLINE PLC2.37%88 637
JOHNSON & JOHNSON1.61%421 022
ROCHE HOLDING AG-0.02%288 425
PFIZER INC.0.95%207 340
NOVARTIS AG-4.51%195 369
MERCK & CO., INC.-6.60%193 391
ABBVIE INC.-1.17%186 895
ELI LILLY AND COMPANY8.39%166 346
NOVO NORDISK A/S2.82%162 882
AMGEN INC.8.71%143 732
BRISTOL-MYERS SQUIBB COMPANY2.50%142 547
ASTRAZENECA PLC-0.72%131 672
SANOFI6.73%125 614
GLAXOSMITHKLINE PLC-3.90%88 637
JIANGSU HENGRUI MEDICINE CO., LTD.-26.27%69 532
CHUGAI PHARMACEUTICAL CO., LTD.-22.28%64 689
ALLERGAN PLC0.97%63 659
BAYER AG9.85%62 225
TAKEDA PHARMACEUTICAL COMPANY LIMITED-1.07%53 139
DAIICHI SANKYO COMPANY, LIMITED-14.71%52 365
ASTELLAS PHARMA INC.3.73%28 058
Brand Portfolio
GLAXOSMITHKLINE
GLAXOSMITHKLINE
GSK
GSK
CELLZOME
CELLZOME
CORIXA
CORIXA
DOMANTIS
DOMANTIS
GENELABS TECHNOLOGIES
GENELABS TECHNOLOGIES
GLYCOVAXYN
GLYCOVAXYN
PARODONTAX
PARODONTAX
STIEFEL
STIEFEL
TESARO
TESARO
» More brands of GlaxoSmithKline Plc